Maintained activity in ankylosing spondylitis patients treated with TNFi and/or NSAID for at least 12 weeks: a cross-sectional study in Brazil.

Ricardo Acayaba de ToledoFelipe Merchan Ferraz GrizzoVander FernandesRenato CalheirosRicardo T RussoGustavo RosalLuiz Roberto Delboni MarcheseRoberto TunalaRenato WatanabeMarina Gabriela BirckGuilherme Silva JulianFrancisco Jose Forestiero

Published in: Advances in rheumatology (London, England) (2022)

This real-world study showed that most AS patients on TNFi and/or NSAID had not achieved an adequate disease control, as almost 75% of them exhibited active disease or low activity/suboptimal disease control. There remains a need for improved disease management among patients with AS.

Keyphrases

ankylosing spondylitis
end stage renal disease
newly diagnosed
physical activity
peritoneal dialysis
gestational age